References
- 1. RAUT CP, GRAU AM, STAERKEL GA, et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg. 2003; 7(1):118-28.
- 2. ELOUBEIDI MA, CHEN VK, ISAM A, ELTOUM IA, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. The American Journal of Gastroenterology .2003; 98:2663-8.
- 3. HAREWOOD G, WIERSEMA MJ. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. The American Journal of Gastroenterology.2002; 97: 1386-91.
- 4. YLAGAN LR, EDMUNDOWICZ S, KASAL K, et al. Endoscopic ultrasound guided fine-needle aspiration cytology of pancreatic carcinoma. A 3-year experience and review of the literature. Cancer Cytopathology. 2002; 96(6):362-9.
- 5. FRITSCHER-RAVENS A, IZBICKI JB, SRIRAM VJP, et al. Endosonography-guided, fine-needle aspiration cytology extending the indication for organ-preserving pancreatic surgery. The American Journal of Gastroenterology.2000; 95:2255-60.
- 6. AFIFY AM, AL-KHAFAJI BM, KIM B, SCHEIMAN JM et al. Endoscopic ultrasound-guided fine needle aspiration of the pancreas. Diagnostic utility and accuracy. Acta Cytologica. 2003: 47(3):341-8.
- 7. MICHAEL JONATHAN HEWITT, MCPHAIL, MRCP, LUCIA POSSAMAI, AMEET DHAR, PANAGIOTIS VLAVIANOS,, KEVIN J. MONAHAN. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointestinal Endoscopy.2012; 75(2):319-31.
- 8. DEMAY RM. The art and science of cytopathology: pancreas. Chicago: ASCP Press. 1996: 1059-69.
- 9. NIEDERHUBER JE, MURRAY F. BRENNAN, HERMAN R. MENCK . The national cancer data base report on pancreatic cancer. Cancer. 1995; 76 (9): 1671-77.
- 10. BECKINGHAM IJ. ABC of liver, pancreas and gallbladder, 1st ed. London: BMJ: 2001.
- 11. GREENBLATT DY, KELLY KJ, RAJAMANICKAM V. Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Annals of Surgical Oncology. 2011; 18(8):2126-35.
- 12. NOH KW, WALLACE MB. Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic adenocarcinoma. MedGenMed. 2005; 7(2): 15- 19.
- 13. BRET PM, VIVIANE NICOLET V, LABADIE M. Percutaneous fine-needle aspiration biopsy of the pancreas. Diagnostic Cytopathology.1986; 2(3):221-7.
- 14. BRANDT KR, CHARBONEAU JW, STEPHENS DH, et al. CT- and US-guided biopsy of the pancreas. Radiology. 1993; 187: 99-104.
- 15. LEE JG, LEUNG J. Tissue sampling at ERCP in suspected pancreatic cancer. Gastrointestinal Endoscopy Clinics of North America. 1998; 8(1):221-35.
- 16. PAQUIN SC, GARIÉPY G, LEPANTO L, et al. A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma. Gastrointest Endosc. 2005 Apr; 61(4):610-1.
- 17. MITCHELL ML, CARNEY CN. Cytologic criteria for the diagnosis of pancreatic carcinoma. American Journal of Clinical Pathology. 1985; 83(2):171-6.
- 18. COHEN MB, EGERTER DP, HOLLY EA, AHN DK, MILLER TR. Pancreatic adenocarcinoma: Regression analysis to identify improved cytologic criteria. Diagnostic Cytopathology.1991; 7(4):341-5.
- 19. ROBINS DB, KATZ RL, EVANS DB, ATKINSON EN, GREEN L. Fine needle aspiration of the pancreas. In quest of accuracy. Acta Cytologica. 1995; 39(1):1-10.
- 20. FEKETE PS, NUNEZ C, DEBORAH A. PITLIK DA. Fine-needle aspiration biopsy of the pancreas: A study of 61 cases. Diagnostic Cytopathology. 1986; 2(4):301-6.
- 21. AL-KAISI N, SIEGLER EE. Fine needle aspiration cytology of the pancreas. Acta Cytologica. 1989; 33(2):145-52.
- 22. KOCJAN G, RODE J, LEES WR. Percutaneous fine needle aspiration cytology of the pancreas: advantages and pitfalls. J Clin Pathol 1989; 42:341-7.
- 23. BRITS CJ, FRANZ RC. Pale nodular nuclei-diagnostic of adenocarcinoma of the pancreas? Acta Cytologica. 1976; 20(5):462-8.
- 24. LIN F, STAERKEL GM. Cytologic criteria for well differentiated adenocarcinoma of the pancreas in fine-needle aspiration biopsy specimens. Cancer Cytopathology. 2003; 99(1):44-50.
- 25. LIN F, JIANHUI S, HAIYAN L, et al. Diagnostic utility of S100P and von Hippel-Lindau Gene Product (pVHL) in pancreatic adenocarcinoma - with implication of their roles in early tumorigenesis. American Journal of Surgical Pathology. 2008; 32(1):78-91.
- 26. LEVY M, LIN F, XU H, DHALL D, BETSY O. SPAULDING BO, WANG HL. S100P, von Hippel-Lindau gene product and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy. Human Pathology. 2010; 41(9):1210-1219.
- 27. ZHAO H, MANDICH D , RICHARD W. CARTUN RW, LIGATO S. Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas. Diagnostic Cytopathology.2007; 35(11):700-4.
- 28. KYOKO K, NOBUYUKI O, SEISHIRO M, MASASHI S, MANABU T, TOSHIO M. Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas. Hepatobiliary Pancreat Dis Int. 2008; 7(1):86-90.
- 29. AGARWAL B, LUDWIG, OJ, BRIAN T. COLLINS BT, CORTESE C. Immunostaining as an adjunct to cytology for diagnosis of pancreatic adenocarcinoma. Clinical Gastroenterology and Hepatology. 2008; 6(12):1425-1431.
- 30. MCCARTHY DM, MAITRA A; ARGANI P, et al. Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: Mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Applied Immunohistochemistry & Molecular Morphology. 2003; 11(3):238-43.
- 31. HASSAN R, LASZIK ZG, MEGAN LERNER M, RAFFELD M, POSTIER R, BRACKETT D. Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis. American Journal of Clinical Pathology.2005; 124: 838-845.
- 32. KARANJAWALA ZE, ILLEI PB, ASHFAQ R, et al. New markers of pancreatic cancer identified through differential gene expression analyses: Claudin 18 and Annexin A8. Am J Surg Pathol. 2008; 32(2): 188-196.
- 33. DE LOTT LB, MORRISON C, SUSTER S, COHN DE, FRANKEL WL. CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites. Arch Pathol Lab Med. 2005; 129(9):1100-5.
- 34. GOLDSTEIN NS, BASSI D. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold. Am J Clin Pathol. 2001; 115(5):695-702.
- 35. CHU PG, SCHWARZ RE, LAU, SK, YEN Y, WEISS L. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of vater adenocarcinoma: Application of CDX2, CK17, MUC1, and MUC2. American Journal of Surgical Pathology. 2005; 29(3):359-367.
- 36. LAU SK, PRAKASH S, GELLER SA, ALSABEH R. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Human Pathology 2002; 33(12):1175-1181.
- 37. KOHJI NAGATA, MICHIKO HORINOUCHI, MIYUKI SAITOU, et al. Mucin expression profile in pancreatic cancer and the precursor lesions. Journal of Hepato-Biliary-Pancreatic Surgery.2007; 14(3):243-254.
- 38. NIRAG JHALA, DARSHANA JHALA, SELWYN M. VICKERS, et al. Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates: A translational research application. American Journal of Clinical Pathology. 2006: 126:572-9.
- 39. TAMAR A. GIORGADZE, HEATHER PETERMAN, ZUBAIR BALOCH, et al. Diagnostic utility of mucin profile in fineneedle aspiration specimens of the pancreas: An immunohistochemical study with surgical pathology correlation. Cancer Cytopathology. 2006; 108(3):186-197.
- 40. KOSARAC O, TAKEI H, ZHAI QJ, SCHWARTZ MR, MODY DR. S100P and XIAP expression in pancreatic ductal adenocarcinoma: Potential novel biomarkers as a diagnostic adjunct to fine needle aspiration cytology. Acta Cytologica 2011; 55: 142-148.
- 41. WACHTER DL, SCHLABRAKOWSKI A, HOEGEL J, KRISTIANSEN G, HARTMANN A, RIENER MO. Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma. American Journal of Surgical Pathology. 2011; 35(6):873-877.
- 42. LIU H, SHI J, ANANDAN V, WANG HL, DIEHL D, BLANSFIELD J, GERHARD G, LIN F. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas. Arch Pathol Lab Med. 2012;136(6):601-9.
- 43. DANIEL C. DIM , FENG JIANG, QI QIU, TING, PETER DARWIN, WILLIAM H. RODGERS, HONG QI PENG. The usefulness of S100P, mesothelin, fascin, prostate stem cell antigen, and 14-3-3 sigma in diagnosing pancreatic adenocarcinoma in cytological specimens obtained by endoscopic ultrasound guided fine-needle aspiration. Diagnostic Cytopathology 2014; 42(3):193-9.
- 44. TAKAHASHI K, YAMAO K, OKUBO K et al. Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA. Gastrointest. Endosc. 2005; 61: 76-9.
- 45. HOSODA W, TAKAGI T, MIZUNO N et.al. Diagnostic approach to pancreatic tumor with the specimens of endoscopic ultrasound-guided fine needle aspiration. Pathol. Int. 2010; 60: 358-64.
- 46. DENG H, SHI J, WILKERSON M, FUPREE W, LIN F. Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine needle aspiration biopsy specimens. Am. J. Clin. Pathol. 2008; 129: 81-8.
- 47. GIORGADZE TA, PETERMAN H, BALOCH ZW et al. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas. Cancer Cytopathol. 2006; 108: 186-97.
- 48. KROEP JR, LOVES WJ, VAN DER WILT CL et al. Pretreatment deoxycytidine linase levels predict in vivo gemcitabine sensitivity. Mol. Cancer Ther. 2002; 1: 371-6.
- 49. ASHIDA R, NAKATA B, SHIGEKAWA M et al. Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasoundguided fine-needle aspiration biopsy of unresectable pancreatic cancer. J. Exp. Clin. Cancer Res. 2009; 28: 83.
- 50. GIOVANNETTI E, DEL TACCA M, MEY V et al. Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine. Cancer Res. 2006; 66: 3928-35.
- 51. FUJITA H, OHUCHIDA K, MIZUMOTO K et al. Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Neoplasia 2010; 12: 807-10.
- 52. YOSHINAGA S, SUZUKI H, ODA I, SAITO Y. Role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of solid pancreatic masses. Dig Endosc. 2011; 23 Suppl 1:29-33.